4.7 Article

The DEK oncoprotein is a Su(var) that is essential to heterochromatin integrity

Journal

GENES & DEVELOPMENT
Volume 25, Issue 7, Pages 673-678

Publisher

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.2036411

Keywords

heterochromatin; oncogene; HP1-alpha; epigenetics; Su(var)

Funding

  1. Arthritis Foundation/Michigan Chapter
  2. Arthritis Foundation
  3. NIH [T32-GM07863, R01-AI062248, R01-AI087128, 1K99CA129565-01A1]
  4. National Science Foundation
  5. Rackham Predoctoral Fellowships
  6. Burroughs Wellcome Fund Clinical Scientist Award in Translational Research
  7. Department of Defense [PC080665]
  8. Max Planck Society
  9. Deutsche Forschungsgemeinschaft [SFB 746]
  10. Human Frontier Science Program
  11. EU (the Epigenome)
  12. European Research Council
  13. CellNetworks-Cluster of Excellence [EXC81]

Ask authors/readers for more resources

Heterochromatin integrity is crucial for genome stability and regulation of gene expression, but the factors involved in mammalian heterochromatin biology are only incompletely understood. Here we identify the oncoprotein DEK, an abundant nuclear protein with a previously enigmatic in vivo function, as a Suppressor of Variegation [Su(var)] that is crucial to global heterochromatin integrity. We show that DEK interacts directly with Heterochromatin Protein 1 alpha (HP1 alpha) and markedly enhances its binding to trimethylated H3K9 (H3K9me3), which is key for maintaining heterochromatic regions. Loss of Dek in Drosophila leads to a Su(var) phenotype and global reduction in heterochromatin. Thus, these findings show that DEK is a key factor in maintaining the balance between heterochromatin and euchromatin in vivo.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available